CX3CR1 labels a specific CD8+ T cell population in the circulation of grade 4 glioma patients.
(A) CD8+ T cell cluster highlighted on tSNE map (left). CD8+ T cell cluster colored by site of origin (right). (B) Volcano plot showing differentially expressed genes (FDR corrected p value < 0.05, indicated by blue and green) in CD8+ T cells from tumor-periphery versus PBMC. For a complete list of differentially expressed genes per cell cluster between tumor periphery and PBMC, please refer to Supplementary File 6. (C) Frequency of CX3CR1+ CD8+ T cells among all CD8+ T cells in flow cytometry data (Figure 5 – source data 1). (D) Unsupervised hierarchical sub-clustering of CD8+ T cells from PBMC and Periphery revealed two transcriptionally distinct subsets of PBMC CD8+ T cells, displayed on the tSNE map. (E) Expression of CX3CR1 overlaid on tSNE CD8+ T cell cluster. (F) Expression of genes associated with effector memory phenotype overlaid on tSNE CD8+ T cell cluster. Displayed genes are significantly, differentially expressed genes (DEGs) between tumor periphery and PBMC, as identified by differential gene expression analysis shown in panel (B). (G) Expression of selected genes associated with naive phenotype overlaid on tSNE CD8+ T cell cluster (H) Gating procedure applied to identify CD3+ CD8+ naïve, T effector cells (Teff), effector memory (Tem), peripheral memory (Tpm) and central memory (Tcm), eluted from PBMCs. (I) Expression of CX3CR1 in PBMC CD8+ T cell subpopulations identified in (H) (Figure 5 – source data 2). n = 6 donors (C), n = 11 donors (I). Statistics: Wilcoxon matched-pairs signed rank test (C); repeated measures oneway ANOVA with post-hoc Šidák’s correction for multiple comparisons (I). *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001, no brackets indicate no significant difference.